Chelating agent inhibition of Trypanosoma cruzi epimastigotes in vitro.

[1]  J. Molenda,et al.  Synthesis and iron(III) binding properties of 3-hydroxypyrid-4-ones derived from kojic acid. , 1994, Journal of inorganic biochemistry.

[2]  G. Weinberg.  Iron chelators as therapeutic agents against Pneumocystis carinii , 1994, Antimicrobial Agents and Chemotherapy.

[3]  E. Segura,et al.  Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. , 1994, American heart journal.

[4]  L V Kirchhoff,et al.  Chagas disease. American trypanosomiasis. , 1993, Infectious disease clinics of North America.

[5]  S. Orrenius,et al.  Chelation of intracellular zinc triggers apoptosis in mature thymocytes. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[6]  S. D. Castro.  The challenge of Chagas' disease chemotherapy: An update of drugs assayed against Trypanosoma cruzi , 1993 .

[7]  P. Gessner,et al.  Disulfiram and its Metabolite, Diethyldithiocarbamate , 1992, Springer Netherlands.

[8]  L. M. Atkins,et al.  Cadmium mobilization in vivo by intraperitoneal or oral administration of monoalkyl esters of meso-2,3-dimercaptosuccinic acid in the mouse. , 1992, Pharmacology & toxicology.

[9]  D. Anthony,et al.  Covalent cross-linking of proteins by carbon disulfide. , 1992, Chemical research in toxicology.

[10]  B. Mester,et al.  Research for new antichagasic drugs. , 1991, Chemical & pharmaceutical bulletin.

[11]  Marr Jj.  Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis. , 1991 .

[12]  J. Eaton,et al.  Hemolytic and microbicidal actions of diethyldithiocarbamic acid. , 1991, Biochemical pharmacology.

[13]  L. M. Atkins,et al.  Chirality, charge, and chain branching effects on dithiocarbamate-induced mobilization of cadmium from intracellular deposits in mice. , 1991, Chemical research in toxicology.

[14]  L. M. Atkins,et al.  Effect of chelating agent structure on the mobilization of cadmium from intracellular deposits. , 1989, Journal of toxicology and environmental health.

[15]  C. Giulivi,et al.  Chemiluminescence enhancement by trypanocidal drugs and by inhibitors of antioxidant enzymes in Trypanosoma cruzi. , 1988, Molecular and biochemical parasitology.

[16]  J. Eaton,et al.  Antimalarial properties of orally active iron chelators , 1988 .

[17]  M. Jones,et al.  Use of the Topliss scheme for the design of more effective chelating agents for cadmium decorporation. , 1988, Chemical research in toxicology.

[18]  J. Castro,et al.  Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas' disease). , 1988, Biomedical and environmental sciences : BES.

[19]  V. Loo,et al.  Role of iron in intracellular growth of Trypanosoma cruzi , 1984, Infection and immunity.

[20]  B. Holbein,et al.  Role of iron in Trypanosoma cruzi infection of mice. , 1984, The Journal of clinical investigation.

[21]  J. Eaton,et al.  Iron-containing superoxide dismutase from Crithidia fasciculata. Purification, characterization, and similarity to Leishmanial and trypanosomal enzymes. , 1983, The Journal of biological chemistry.

[22]  G. Anderegg,et al.  Pyridinderivate als Komplexbildner. XI†. Die Thermodynamik der Metallkomplexbildung mit Bis-, Tris- und Tetrakis[(2-pyridyl)methyl]-aminen , 1977 .

[23]  G. Anderegg,et al.  Pyridinderivate als Komplexbildner VIII Die Herstellung je eines neuen vier‐ und sechszähnigen Liganden , 1967 .

[24]  R. A. Ludwig,et al.  The Dithiocarbamates and Related Compounds , 1962 .